Visentin, J., Jia, W., Poe, J. C., Su, H., Christina, S., DiCioccio, R. A., … Sarantopoulos, S. (2022). The DNA-Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease. In Blood (Vol. 140, pp. 1161–1162). American Society of Hematology. https://doi.org/10.1182/blood-2022-163635

Visentin, Jonathan, Wei Jia, Jonathan C. Poe, Hsuan Su, Sofian Christina, Rachel A. DiCioccio, Itaevia Curry-Chisolm, et al. “The DNA-Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease.” In Blood, 140:1161–62. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-163635.

Visentin J, Jia W, Poe JC, Su H, Christina S, DiCioccio RA, et al. The DNA-Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease. In: Blood. American Society of Hematology; 2022. p. 1161–2.

Visentin, Jonathan, et al. “The DNA-Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 1161–62. Crossref, doi:10.1182/blood-2022-163635.

Visentin J, Jia W, Poe JC, Su H, Christina S, DiCioccio RA, Curry-Chisolm I, Basher F, Bracken S, Ho VT, Sisirak V, Horwitz ME, Chao NJ, Sarantopoulos S. The DNA-Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease. Blood. American Society of Hematology; 2022. p. 1161–1162.